Portal de Periódicos da CAPES

Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.

1998; Radiological Society of North America; Volume: 206; Issue: 2 Linguagem: Inglês

10.1148/radiology.206.2.9457190

1527-1315

James Ryan, Peter B. Kelsey, Barbara M. Ryan, Peter R. Müeller,

Cancer Diagnosis and Treatment

Alendronate sodium, an aminobiphosphonate used primarily to treat osteoporosis in postmenopausal women, is known to cause esophagitis. A 71-year-old woman experienced severe, acute esophagitis and severe stricture of the esophagus due to oral alendronate therapy. Unlike in previous cases, she had taken alendronate for 10 months before the onset of complications and the stricture proved resistant to dilation.